Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 4 | $60,700,210 |
Sells | 129 | $20,005,523 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
06 Oct 2023 17:10 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 05 Oct 2023 | Sale | 4,345 | 36.39 | 158,115 | D |
05 Dec 2023 16:28 | IMVT | Immunovant Inc | PANDE ATUL | Director | 01 Dec 2023 | Sale | 4,129 | 38.8 | 160,205 | D |
05 Dec 2023 16:25 | IMVT | Immunovant Inc | MIGAUSKY GEORGE V | Director | 01 Dec 2023 | Sale | 4,200 | 38.79 | 162,918 | D |
11 Oct 2023 16:11 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 10 Oct 2023 | Sale | 4,557 | 36.92 | 168,244 | D |
19 Apr 2024 18:05 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 17 Apr 2024 | Sale | 6,136 | 28.8 | 176,717 | D |
27 Jan 2023 07:20 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 26 Jan 2023 | Sale | 10,156 | 18.51 | 187,988 | D |
05 Dec 2023 16:30 | IMVT | Immunovant Inc | FROMKIN ANDREW J. | Director | 01 Dec 2023 | Sale | 4,773 | 40.46 | 193,116 | D |
05 Dec 2023 16:28 | IMVT | Immunovant Inc | PANDE ATUL | Director | 01 Dec 2023 | Sale | 4,847 | 40.46 | 196,110 | D |
05 Dec 2023 16:25 | IMVT | Immunovant Inc | MIGAUSKY GEORGE V | Director | 01 Dec 2023 | Sale | 5,022 | 40.46 | 203,190 | D |
26 Apr 2024 17:20 | IMVT | Immunovant Inc | STOUT JAY S | Chief Technology Officer | 24 Apr 2024 | Sale | 7,239 | 28.9 | 209,207 | D |
19 Apr 2024 18:06 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 17 Apr 2024 | Sale | 7,602 | 28.8 | 218,938 | D |
19 Apr 2024 17:59 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 17 Apr 2024 | Sale | 7,825 | 28.8 | 225,360 | D |
19 Apr 2024 17:57 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 17 Apr 2024 | Sale | 7,714 | 29.94 | 230,957 | D |
19 Jul 2024 17:36 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 17 Jul 2024 | Sale | 8,175 | 29.64 | 242,307 | D |
16 Aug 2023 16:11 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 14 Aug 2023 | Sale | 11,314 | 22.04 | 249,361 | D |
25 Aug 2023 17:05 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 24 Aug 2023 | Sale | 12,285 | 20.3 | 249,386 | D |
25 Aug 2023 17:00 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 24 Aug 2023 | Sale | 12,332 | 20.3 | 250,340 | D |
25 Aug 2023 16:57 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 24 Aug 2023 | Sale | 12,332 | 20.3 | 250,340 | D |
19 Apr 2024 18:01 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 17 Apr 2024 | Sale | 9,479 | 28.8 | 272,995 | D |
25 Aug 2023 17:03 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 24 Aug 2023 | Sale | 14,385 | 20.3 | 292,016 | D |
29 Jan 2024 16:11 | IMVT | Immunovant Inc | GEFFNER MICHAEL | Chief Medical Officer | 26 Jan 2024 | Sale | 9,948 | 37.91 | 377,129 | D |
23 Aug 2024 16:07 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 21 Aug 2024 | Sale | 14,470 | 31.84 | 460,725 | D |
24 May 2024 16:15 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 22 May 2024 | Sale | 16,163 | 29.65 | 479,233 | D |
23 Feb 2024 16:11 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 22 Feb 2024 | Sale | 13,454 | 36.15 | 486,362 | D |
24 Nov 2023 14:55 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 22 Nov 2023 | Sale | 15,601 | 32.75 | 510,933 | D |
13 Jan 2023 08:13 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 11 Jan 2023 | Sale | 44,448 | 16.75 | 744,504 | D |
19 Apr 2024 17:57 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 17 Apr 2024 | Sale | 26,365 | 28.8 | 759,312 | D |
13 Jan 2023 08:19 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Dev. & Tech. Officer | 11 Jan 2023 | Sale | 60,471 | 16.79 | 1,015,308 | D |
01 Sep 2023 16:08 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 30 Aug 2023 | Sale | 50,866 | 21.97 | 1,117,526 | D |
16 Aug 2023 16:11 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 14 Aug 2023 | Sale | 91,744 | 21.34 | 1,957,817 | D |
08 Aug 2023 16:44 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 07 Aug 2023 | Sale | 101,339 | 21.73 | 2,202,096 | D |
07 Oct 2022 16:32 | IMVT | Immunovant Inc | ROIVANT SCIENCES LTD. | 10% | 06 Oct 2022 | Purchase | 416,667 | 6 | 2,500,002 | D |
04 Oct 2023 17:15 | IMVT | Immunovant Inc | ROIVANT SCIENCES LTD. | Director , 10% | 02 Oct 2023 | Purchase | 1,526,316 | 38 | 58,000,008 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)